Company news

Bonus Biogroup Ltd. news in 2025

Bonus Biogroup Ltd.'s news releases, calls and decks from 2025, newest first.

Bonus Biogroup Appoints Renowned Cell Therapy Leader, Professor Edwin M. Horwitz, MD, PhD, to its Advisory Board

July 14, 2025

Bonus Biogroup Announces U.S. Food and Drug Administration (FDA) Clearance of an Investigational New Drug (IND) Application for MesenCure™ Phase III Clinical Study in Respiratory Distress

February 20, 2025

Decks in 2025

Investor Presentation (2025)
Investor deck · 42 slides · 2025